CompletedNot Applicable

Study on the Use of the Insulin Pump Tandem X:2 With Control IQ Algorithm - Update

Germany50 participantsStarted 2021-03-03

Plain-language summary

The aim of this observational clinical trial is to obtain data on the safety, efficacy and satisfaction of the Tandem T:Slim X:2 Pump System in patients with type 1 diabetes.

Who can participate

Age range6 Years – 45 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. signed informed consent
✓. type 1 diabetes
✓. Age \>6 years
✓. at least 10 IE daily total Insulin dose and 25 kg Body weight
✓. Group SWITCH: already user of t:slim X2 with Basal IQ
✓. Group START: Granting of the insulin pump t:slim X2 and DexCom G6 by the health insurance

Exclusion criteria

✕.Refusal of participation by the participant or a parent

What they're measuring

Time in glucose range 70 - 180mg/dl (%)

Timeframe: 12 weeks

Trial details

NCT IDNCT05118945

SponsorKinderkrankenhaus auf der Bult

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2021-12-28

View on ClinicalTrials.gov More Type 1 Diabetes trials